Skip to main content
FinSpry Logo
FinSpry
BMY logo
BMY
(NYSE)
Bristol-Myers Squibb Company
$61.51-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Bristol-Myers Squibb Company (BMY) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Bristol-Myers Squibb Company stock.

Analyst Consensus Rating

Investment consensus from 22 professional research analysts

Consensus Rating

Buy
Based on 22 unique analysts
(31 total ratings in last 90 days)
Very High Confidence11.0:1 Buy/Sell

Average Price Target

$63.58
↑ 3.37% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BMY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Evan Seigerman
BMO Capital
HoldMaintains
$60.00
Mohit Bansal
Wells Fargo
HoldMaintains
$60.00
Seamus Fernandez
Guggenheim
BuyMaintains
$72.00
Jason Gerberry
BofA Securities
BuyReiterates
$67.00 → $66.00
Trung Huynh
RBC Capital
HoldMaintains
$60.00
Louise Chen
Scotiabank
HoldMaintains
$60.00
Trung Huynh
RBC Capital
HoldMaintains
$60.00
Courtney Breen
Bernstein
HoldMaintains
-
Seamus Fernandez
Guggenheim
BuyMaintains
$72.00
Michael Yee
UBS
BuyMaintains
$70.00
Courtney Breen
Bernstein
HoldMaintains
-
Emily Field
Barclays
BuyMaintains
$75.00
Louise Chen
Scotiabank
HoldMaintains
$60.00
David Amsellem
Piper Sandler
BuyReiterates
$75.00
Unknown Analyst
Jefferies
BuyMaintains
$70.00 → $73.00
Geoff Meacham
Citi
HoldMaintains
$66.00
Geoff Meacham
Citi
HoldMaintains
$66.00
Asad Haider
Goldman Sachs
HoldMaintains
$61.00
Terence Flynn
Morgan Stanley
SellMaintains
$40.00
Mohit Bansal
Wells Fargo
HoldMaintains
$60.00
Jason Gerberry
BofA Securities
BuyReiterates
$67.00
Evan Seigerman
BMO Capital
HoldMaintains
$60.00
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$69.00 → $63.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$66.00 → $63.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldReiterates
$63.00 → $57.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
BuyReiterates
$70.00 → $64.00
xAi Drug Manufacturers - General
TipRanks - xAI
BuyReiterates
$66.00 → $63.00
OpenAI Drug Manufacturers - General
TipRanks - OpenAI
HoldReiterates
$66.00 → $60.00
Srikripa Devarakonda
Truist
BuyMaintains
-
Matt Phipps
William Blair
HoldMaintains
-
Trung Huynh
RBC Capital
HoldMaintains
$60.00

Frequently Asked Questions

What is the analyst consensus rating for BMY?

The analyst consensus rating for BMY is "Buy" based on 22 analyst recommendations.

What is the average price target for BMY?

The average 12-month price target for BMY is $63.58, representing an upside of 3.4% from the current price of $61.51.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.